| |
| |
|
| Insider
Information: |
Gray William Garrett |
| Relationship: |
Chief Financial Officer |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
145,224 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$294,805 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
145,224 |
|
|
| Total
Value |
$294,805 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
11
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
9
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -308.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Checkpoint Therapeutics, Inc. |
CKPT |
Chief Financial Officer |
2024-02-28 |
145,224 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CKPT |
Checkpoint Therapeutics, ... |
Chief Financial Officer |
• – – |
2024-02-28 |
4 |
S |
$2.07 |
$4,212 |
D/D |
(2,035) |
145,224 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
Chief Financial Officer |
• – – |
2024-02-01 |
4 |
S |
$1.95 |
$8,024 |
D/D |
(4,115) |
147,259 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
Chief Financial Officer |
• – – |
2023-03-02 |
4 |
S |
$5.00 |
$17,955 |
D/D |
(3,591) |
51,374 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
Chief Financial Officer |
• – – |
2023-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
54,965 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
Chief Financial Officer |
• – – |
2023-02-27 |
4 |
S |
$4.66 |
$8,919 |
D/D |
(1,914) |
47,465 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
Chief Financial Officer |
• – – |
2023-02-01 |
4 |
S |
$4.79 |
$15,108 |
D/D |
(3,154) |
49,379 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
Chief Financial Officer |
• – – |
2023-01-10 |
4 |
S |
$6.75 |
$12,540 |
D/D |
(1,858) |
52,533 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
Chief Financial Officer |
• – – |
2022-03-10 |
4 |
S |
$1.89 |
$72,307 |
D/D |
(38,197) |
543,910 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
Chief Financial Officer |
• – – |
2022-02-01 |
4 |
S |
$2.51 |
$92,954 |
D/D |
(37,063) |
582,107 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
Chief Financial Officer |
• – – |
2022-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
137,000 |
619,170 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
Chief Financial Officer |
• – – |
2021-02-04 |
4 |
S |
$3.66 |
$96,318 |
D/D |
(26,320) |
482,170 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
Chief Financial Officer |
• – – |
2021-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
151,000 |
508,490 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
Chief Financial Officer |
• – – |
2020-12-22 |
4 |
S |
$2.79 |
$6,712 |
D/D |
(2,406) |
357,490 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
See Remarks |
• – – |
2020-05-21 |
4 |
S |
$2.00 |
$34,122 |
D/D |
(17,104) |
359,896 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
See Remarks |
• – – |
2020-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
157,000 |
377,000 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
See Remarks |
• – – |
2019-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
90,000 |
220,000 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
See Remarks |
• – – |
2018-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
130,000 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
See RemarksOfficer |
• – – |
2016-12-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
80,000 |
|
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
